These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 33246136)

  • 1. Type I interferon in the pathogenesis of systemic lupus erythematosus.
    Postal M; Vivaldo JF; Fernandez-Ruiz R; Paredes JL; Appenzeller S; Niewold TB
    Curr Opin Immunol; 2020 Dec; 67():87-94. PubMed ID: 33246136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus.
    Oke V; Gunnarsson I; Dorschner J; Eketjäll S; Zickert A; Niewold TB; Svenungsson E
    Arthritis Res Ther; 2019 Apr; 21(1):107. PubMed ID: 31036046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I interferon and systemic lupus erythematosus.
    Elkon KB; Stone VV
    J Interferon Cytokine Res; 2011 Nov; 31(11):803-12. PubMed ID: 21859344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I interferon in systemic lupus erythematosus.
    Crow MK
    Curr Top Microbiol Immunol; 2007; 316():359-86. PubMed ID: 17969456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification.
    Munroe ME; Lu R; Zhao YD; Fife DA; Robertson JM; Guthridge JM; Niewold TB; Tsokos GC; Keith MP; Harley JB; James JA
    Ann Rheum Dis; 2016 Nov; 75(11):2014-2021. PubMed ID: 27088255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities of the type I interferon signaling pathway in lupus autoimmunity.
    Gallucci S; Meka S; Gamero AM
    Cytokine; 2021 Oct; 146():155633. PubMed ID: 34340046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Type-I IFN subtype autoantibodies and activity in SLE serum and urine.
    Harris BD; Kuruganti S; Deshpande A; Goepfert PA; Chatham WW; Walter MR
    Lupus; 2020 Aug; 29(9):1095-1105. PubMed ID: 32611267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markers.
    Chasset F; Ribi C; Trendelenburg M; Huynh-Do U; Roux-Lombard P; Courvoisier DS; Chizzolini C;
    Rheumatology (Oxford); 2020 Nov; 59(11):3468-3478. PubMed ID: 32375176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of production of type I interferons by B cells in the mechanisms and pathogenesis of systemic lupus erythematosus.
    Hamilton JA; Hsu HC; Mountz JD
    Discov Med; 2018 Jan; 25(135):21-29. PubMed ID: 29466691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cause and consequences of the activated type I interferon system in SLE.
    Eloranta ML; Rönnblom L
    J Mol Med (Berl); 2016 Oct; 94(10):1103-1110. PubMed ID: 27094810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The important roles of type I interferon and interferon-inducible genes in systemic lupus erythematosus.
    Luo S; Wang Y; Zhao M; Lu Q
    Int Immunopharmacol; 2016 Nov; 40():542-549. PubMed ID: 27769023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I interferon pathway in pediatric systemic lupus erythematosus.
    Zhou Y; Song HM
    World J Pediatr; 2024 Jul; 20(7):653-668. PubMed ID: 38914753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon score is increased in incomplete systemic lupus erythematosus and correlates with myxovirus-resistance protein A in blood and skin.
    Lambers WM; de Leeuw K; Doornbos-van der Meer B; Diercks GFH; Bootsma H; Westra J
    Arthritis Res Ther; 2019 Dec; 21(1):260. PubMed ID: 31791398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A compass that points to lupus: genetic studies on type I interferon pathway.
    Kyogoku C; Tsuchiya N
    Genes Immun; 2007 Sep; 8(6):445-55. PubMed ID: 17581625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of interferons in SLE.
    Bengtsson AA; Rönnblom L
    Best Pract Res Clin Rheumatol; 2017 Jun; 31(3):415-428. PubMed ID: 29224681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Cyclin-Dependent Kinase 1 as a Novel Regulator of Type I Interferon Signaling in Systemic Lupus Erythematosus.
    Wu L; Qin Y; Xia S; Dai M; Han X; Wu Y; Zhang X; Ma J; Wang Y; Tang Y; Liu Z; Zhu W; Jallal B; Yao Y; Qu B; Shen N
    Arthritis Rheumatol; 2016 May; 68(5):1222-32. PubMed ID: 26663909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel type I IFN-producing cell subset in murine lupus.
    Lee PY; Weinstein JS; Nacionales DC; Scumpia PO; Li Y; Butfiloski E; van Rooijen N; Moldawer L; Satoh M; Reeves WH
    J Immunol; 2008 Apr; 180(7):5101-8. PubMed ID: 18354236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of autoantibodies against type I and type II interferons in a cohort of systemic lupus erythematosus patients in Slovakia.
    Slavikova M; Schmeisser H; Kontsekova E; Mateicka F; Borecky L; Kontsek P
    J Interferon Cytokine Res; 2003 Mar; 23(3):143-7. PubMed ID: 12716486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type I interferon blockade in systemic lupus erythematosus: where do we stand?
    Lauwerys BR; Ducreux J; Houssiau FA
    Rheumatology (Oxford); 2014 Aug; 53(8):1369-76. PubMed ID: 24344319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.